Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative

Abstract Telomerase reverse transcriptase is crucial for cellular development, regeneration, and disease processes. Strategies for both telomerase activation and inhibition have been intensively explored in the past decades. In this study, we present a highly miniaturized, microarray-based assay des...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia Li Ye, Lu Fan, Christian Bär, Thomas Thum, Oliver Plettenburg, Russell J. Cox, Carsten Zeilinger
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-00230-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850137658392576000
author Jia Li Ye
Lu Fan
Christian Bär
Thomas Thum
Oliver Plettenburg
Russell J. Cox
Carsten Zeilinger
author_facet Jia Li Ye
Lu Fan
Christian Bär
Thomas Thum
Oliver Plettenburg
Russell J. Cox
Carsten Zeilinger
author_sort Jia Li Ye
collection DOAJ
description Abstract Telomerase reverse transcriptase is crucial for cellular development, regeneration, and disease processes. Strategies for both telomerase activation and inhibition have been intensively explored in the past decades. In this study, we present a highly miniaturized, microarray-based assay designed to identify compounds that target telomerase. The active protein was either recombinantly derived from E. coli or obtained from cell lysates of human cancer cell lines and mouse cells expressing telomerase. Using non-contact spotter technology, these lysates or purified telomerase proteins were transferred onto nitrocellulose pads on a microarray. A telomerase binding assay, incorporating fluorescent labelled primer, the template RNA telomerase RNA component, and fluorescent labelled nucleotide as a primer cocktail, was conducted in incubation chambers. Binding of this primer cocktail to spotted telomerase from cell lysates, and from purified recombinant telomerase resulted in an increase in bound fluorescence. Epigallocatechin gallate, a known telomerase inhibitor, reduced this fluorescence in a dose-dependent manner with micromolar affinity. The inhibitory effect on telomerase was validated by thermophoresis and its impact on activity was shown in a Telomerase Repeated Amplification Protocol (TRAP) assay. Additional screening identified that 4’-iodo cytochalasin H inhibits primer cocktail binding to cell lysate in the low micromolar range. Molecular modeling and docking pinpointed a putative binding site for epigallocatechin gallate in a human telomerase homologue, and a putative binding site for 4’-iodo cytochalasin H. In summary, we developed an assay that can be employed to discover new telomerase inhibitors and that will serve as a valuable tool for screening of activators.
format Article
id doaj-art-e9849e42a01d4200a90a560f4cb9e32f
institution OA Journals
issn 2045-2322
language English
publishDate 2025-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e9849e42a01d4200a90a560f4cb9e32f2025-08-20T02:30:46ZengNature PortfolioScientific Reports2045-23222025-06-0115111410.1038/s41598-025-00230-zDevelopment of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivativeJia Li Ye0Lu Fan1Christian Bär2Thomas Thum3Oliver Plettenburg4Russell J. Cox5Carsten Zeilinger6Hannover Medical School, Institute of Molecular and Translational Therapeutic StrategiesCentre of Biomolecular Drug Research (BMWZ) and Institute for Organic Chemistry, Gottfried-Wilhelm-Leibniz University HannoverHannover Medical School, Institute of Molecular and Translational Therapeutic StrategiesHannover Medical School, Institute of Molecular and Translational Therapeutic StrategiesCentre of Biomolecular Drug Research (BMWZ) and Institute for Organic Chemistry, Gottfried-Wilhelm-Leibniz University HannoverCentre of Biomolecular Drug Research (BMWZ) and Institute for Organic Chemistry, Gottfried-Wilhelm-Leibniz University HannoverCentre of Biomolecular Drug Research (BMWZ) and Institute for Organic Chemistry, Gottfried-Wilhelm-Leibniz University HannoverAbstract Telomerase reverse transcriptase is crucial for cellular development, regeneration, and disease processes. Strategies for both telomerase activation and inhibition have been intensively explored in the past decades. In this study, we present a highly miniaturized, microarray-based assay designed to identify compounds that target telomerase. The active protein was either recombinantly derived from E. coli or obtained from cell lysates of human cancer cell lines and mouse cells expressing telomerase. Using non-contact spotter technology, these lysates or purified telomerase proteins were transferred onto nitrocellulose pads on a microarray. A telomerase binding assay, incorporating fluorescent labelled primer, the template RNA telomerase RNA component, and fluorescent labelled nucleotide as a primer cocktail, was conducted in incubation chambers. Binding of this primer cocktail to spotted telomerase from cell lysates, and from purified recombinant telomerase resulted in an increase in bound fluorescence. Epigallocatechin gallate, a known telomerase inhibitor, reduced this fluorescence in a dose-dependent manner with micromolar affinity. The inhibitory effect on telomerase was validated by thermophoresis and its impact on activity was shown in a Telomerase Repeated Amplification Protocol (TRAP) assay. Additional screening identified that 4’-iodo cytochalasin H inhibits primer cocktail binding to cell lysate in the low micromolar range. Molecular modeling and docking pinpointed a putative binding site for epigallocatechin gallate in a human telomerase homologue, and a putative binding site for 4’-iodo cytochalasin H. In summary, we developed an assay that can be employed to discover new telomerase inhibitors and that will serve as a valuable tool for screening of activators.https://doi.org/10.1038/s41598-025-00230-z
spellingShingle Jia Li Ye
Lu Fan
Christian Bär
Thomas Thum
Oliver Plettenburg
Russell J. Cox
Carsten Zeilinger
Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative
Scientific Reports
title Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative
title_full Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative
title_fullStr Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative
title_full_unstemmed Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative
title_short Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative
title_sort development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative
url https://doi.org/10.1038/s41598-025-00230-z
work_keys_str_mv AT jialiye developmentofamicroarraybasedtelomerasebindingassayrevealsunusualbindingofacytochalasinderivative
AT lufan developmentofamicroarraybasedtelomerasebindingassayrevealsunusualbindingofacytochalasinderivative
AT christianbar developmentofamicroarraybasedtelomerasebindingassayrevealsunusualbindingofacytochalasinderivative
AT thomasthum developmentofamicroarraybasedtelomerasebindingassayrevealsunusualbindingofacytochalasinderivative
AT oliverplettenburg developmentofamicroarraybasedtelomerasebindingassayrevealsunusualbindingofacytochalasinderivative
AT russelljcox developmentofamicroarraybasedtelomerasebindingassayrevealsunusualbindingofacytochalasinderivative
AT carstenzeilinger developmentofamicroarraybasedtelomerasebindingassayrevealsunusualbindingofacytochalasinderivative